Friday Poster Viewing Reception
| Friday, October 10, 2025 |
| 5:00 PM - 6:00 PM |
Speaker
Delfin Lovelina Francis
Saveetha Dental College And Hospitals, Saveetha Institute Of Medical And Technical Sciences (simats), Saveetha Universit
EP01.01: Tobacco Use And Awareness Among Kanchipuram Silk Weavers, Tamil Nadu, India
Delfin Lovelina Francis
Saveetha Dental College And Hospitals, Saveetha Institute Of Medical And Technical Sciences (simats), Saveetha Universit
EP01.02: Tobacco Consumption Pattern Among Auto Rickshaw Drivers in Chennai City, Tamil Nadu, India
Deepak Gupta
Bhagwan Mahaveer Cancer Hospital & Research Center
PP01.72: Efficacy And Safety of Capecitabine And Temozolomide Combination Therapy in Extensive Disease Small Cell Lung Carcinoma: A Prospective Interventional Pilot Study
Yuri Sumi
Japanese Redcross Musashino Hospital
Utility of The Psoas Muscle Index in Pre-Operative Evaluation of Patients With Primary Lung Cancer
Stephen Chun
MD Anderson
Poster Mentor
Kwang Nam Jin
Seoul National University Boramae Medical Center
Poster Mentor
Ying-Long Peng
Guangdong Lung Cancer Institue, GuangdongProvincial People's Hospital
PP01.01: Association And Prognosis of Non-Cancerous Respiratory Diseases to Lung Cancer And Pan-Cancer: Observational And Mendelian Randomization Analysis
Chunxia Su
Shanghai Pulmonary Hospital
Poster Mentor
Chandrashekhar Sreeramareddy
International Medical University
PP01.06: Electronic Cigarette And Heated Tobacco Product Use And Their Association With Tobacco Control Factors Among Adults in Costa Rica, Malaysia, Mauritania, Mexico, And South Africa
Zizi Zhou
Shenzhen Third People's Hospital, The Second Affiliated Hospital, Southern University of Science and Technology
PP01.13: Simultaneous Bilateral Single-Port Video-Assisted Thoracoscopic Surgery (VATS) For Multiple Pulmonary Nodules: Safety, Feasibility, And Outcomes From a Single-Center Experience
Hiroyasu Koga
Yokohama City University
PP01.14: Prognostic Impact of N1 Micrometastasis in pT1–2a Non-Small Cell Lung Cancer: An IPTW-Adjusted Cohort Study
Ayaka Asakawa
Institute of Science Tokyo
PP01.16: Surgery For Elderly Patients With Primary Lung Cancer
Ryohei Matsushima
Kumamoto Universtity Hospital
PP01.17: T1 Lung Cancer With Ground-Glass Opacity Component is Less Likely to Develop Lymph Node Metastasis
Sukarti San Suwarno
Indonesian of Society Respirology
PP01.20: Early Stage Squamous Cell Carcinoma Lung Cancer With Asthma And Lymphadenitis Tuberculosis
Karan Singh Peepre
Nuclear Medicine, Parul University
PP01.21: 18(F) Fluoro-2D-OxyGlucose & PET/CT In The Diagnosis Lung Cancer
Aira Caluag
National Cancer Centre Singapore
PP01.23: A Novel Lung Cancer Patient Navigation (LCPN) Programme in a Tertiary Oncology Centre in Singapore – Through The Consolidated Framework For Implementation Research (CFIR) Lens
Yousra Ben Ajiba
Faculty of Medicine and Pharmacy Tangier-Morocco
PP01.26: Preliminary Insights From a Regional Lung Cancer Registry in Northern Morocco: Epidemiology, Clinical Characteristics, And Therapeutic Profile
Tovuu Lkhagva-Ochir
Second State Central Hospital Mongolia
PP01.28: Last Twenty Years Lung Cancer Incidence And Mortality Rate in Mongolia
Vivek Agarwala
Narayana Health, Howrah & Kolkata
PP01.29: Low-Dose Durvalumab Consolidation After Definitive Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer – A Real-World Multicentre Experience From India
Daisuke Eriguchi
Tokyo Medical University
PP01.31: Perioperative Outcomes of Neoadjuvant Chemoradiotherapy Versus Chemoimmunotherapy For Resectable NSCLC
Kaihua Zhang
China Aerospace Science & Industry Corporation 731 Hospital
PP01.34: Clinical Study on Thoracoscopic Talc Pleurodesis Combined With Subpleural Lesion Resection For Treating Pneumothorax Secondary to Pulmonary Metastasis of Osteosarcoma
Maki Ito
Tokyo Medical University
PP01.36: Strategic Selection of Surgical Approaches For Robot-Assisted Resection of Anterior Mediastinal Tumors
Yoshiaki Takase
Jichi Medical University
PP01.37: Thoracoscopic Hilar Release to Reduce Anastomotic Tension in Extended Tracheal And Carinal Resections For Adenoid Cystic Carcinoma
Nguyen Son Lam
Pham Ngoc Thach Hospital (Retired)
PP01.38: Malignant Pleural Mesothelioma at Pham Ngoc Thach Hospital in 10-Year Retrosprective Study (2013-2023)
Adhitri Anggoro
Universitas Airlangga
PP01.40: Sarcomatoid Malignant Pleural Mesothelioma in a Young Male: Diagnostic And Therapeutic Challenge in an Aggressive Subtype
Shuxin Zhu
Shanghai Jiao Tong University School of Medicine
PP01.41: SPP1+ Macrophage in EGFR Mutant TKI-Resistant Lung Cancer Patients
Libo Tang
Guangdong Lung Cancer Institute
PP01.42: Efficacy And Multi-Omics Insights of Immune Checkpoint Inhibitors in NSCLC With Leptomeningeal Metastasis
Yohei Kawaguchi
Tokyo Medical University
PP01.43: Prospective And Retrospective CT Monitoring of Skeletal Muscle Predicts Outcomes in High-Risk NSCLC Patients on Atezolizumab
Wan Ling Chiu
Taipei City Hospital
PP01.45: Evaluating The Clinical Utility of Combined Biomarkers in Predicting Immunotherapy Response in Advanced NSCLC: An Evidence-Based Medicine Approach
Wei Huo
Dalian Municipal Central Hospital
PP01.46: Camrelizumab Plus Chemotherapy Achieved Long-Term Survival in Advanced Non-Small Cell Lung Cancer: A Real-World Case Series
Mahesh Chaudhary
Homi Bhabha Cancer Hospital, Varanasi
PP01.47: Gut Microbiome And Immunotherapy Response in Indian NSCLC Patients: Results From a Prospective Observational Study
Jiaao Liu
Harbin Medical University Cancer Hospital
PP01.49: Mathematical Model Based on Animal Experiments of Flash Radiotherapy: Exploring The Optimal Dose Rate in Different Tissue Types？
Triparna Sen
PP01.50: SCD1 Inhibition Blocks The AKT-NRF2-SLC7A11 Pathway to Induce Lipid Metabolism Remodeling And Ferroptosis Priming in Lung Adenocarcinoma
Karan Singh Peepre
Nuclear Medicine, Parul University
PP01.51: Role of 18(F) Fluoro-2D-Oxy-Glucose-Positron Emission Tomography imaging In The Accurate Diagnosis & Evaluation of Response to Targeted Therapy in No-Small Cell Lung Cancer
Cindy Kang
Kaohsiung Medical University
PP01.52: Improving Adherence to EGFR Inhibitors: A Multidisciplinary Approach Integrating Nail Bracing For Nail Toxicity Management
Cindy Kang
Kaohsiung Medical University
PP01.53: Tepotinib-Induced Chylous Effusions: A Case Report And Literature Review
Qianlin Huang
Guangdong Lung Cancer Institute
PP01.54: The Outcome of Pemigatinib in Advanced NSCLC With A Novel FGFR Fusion: Case Report
Judy Li
Equihealth
PP01.55: APAC Lung Cancer Policy Final Consensus Statements
Van-Anh Nguyen Hoang
Medical Genetics Institute
PP01.56: Direct Comparison of Tumor-Informed And Tumor-Agnostic ctDNA Assays to Detect Minimal Residual Disease in Early-Stage Non-Small Cell Lung Cancer
Tu Nguyen
GENE SOLUTIONS LAB Co., Ltd.
PP01.59: Circulating Tumor DNA Dynamics to Predict Response to Tyrosine Kinase Inhibitors in Patients With Advanced Non-Small Cell Lung Cancer: An Interim Report
Nam Tran
Gene Solutions Lab LLC
PP01.60: Integrating Tumor Comprehensive Genomic And Transcriptomic Profiling With Plasma ctDNA Monitoring to Maximize Clinical Benefits in Advanced Lung Cancer
Gokul Viknesh
NITRD
PP01.61: Comprehensive Genomic Profiling of Lung Cancer in a Real-World Indian Cohort: A Retrospective Analysis From NITRD, New Delhi
Kenneth Culver
ALK Positive
PP01.62: Powered by Patients: Transcriptional Expression Analysis in ALK-Positive Lung Cancers Identifies Potential Therapeutic Targets
Aditya Manna
Mas Clinic & Hospital
PP01.63: Incidence of Female Lung Cancer in Rural India: The Impact of Cooking Smoke
Jingxiang Shi
Peking University
PP01.64: A Machine Learning-Based Immunoscore Model Via Routine Blood And Biochemical Data For Predicting Prognosis of Lung Cancer Patients
Van Thien-Chi Nguyen
Medical Genetics Institute
PP01.65: A Cost-effective Multimodal cfDNA Assay Improves Lung Cancer Detection in Symptomatic And High-Risk Screening Cohorts
Dang Nguyen
GENE SOLUTIONS LAB COMPANY LIMITED
PP01.68: Clinical Utility of a Multi-omic, cfDNA-based Assay in The Early Detection of Lung Cancer: A Case Series
Arun Kumar
Aarthi Scans
PP01.69: Role of AI Assisted Chest X-ray in Enabling Early Detection of Lung Cancer - Case Series From Developing Country
Triparna Sen
PP01.70: Intratumoral STING Pathway Activation Enhances Anti-Tumor Immune Responses And Therapeutic Efficacy of ATR Inhibition
Liu Yin
The First Affiliated Hospital Of Dalian Medical University
PP01.73: Adebrelimab Plus Chemotherapy For Extensive-Stage Small-Cell Lung Cancer: A Real-World Study
Anupam Datta
NCRI Hospital
PP01.75: Clinical Profile And Patterns of Response in Patients of Neuro-Endocrine Carcinoma Lung: A Single Institutional Descriptive Analysis From Eastern India
Wenqing Lu
Shanghai Jiaotong University School of Medicine
PP01.76: Serotonylation Orchestrates Immune Checkpoint Inhibitor to Promote CD8+ T Cell Anti-Tumor Immunity Through Mitochondrial Function
Sang-youel Park
Jeonbuk National University
PP01.77: Autophagy Flux Inhibition Mediated by Kaempferol Sensitizes Human Lung Cancer Cells to TRAIL-Mediated Apoptosis
